4//SEC Filing
SCP Vitalife Partners (Israel) II, L.P. 4
Accession 0001192482-17-000329
CIK 0001588972other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 4:21 PM ET
Size
10.6 KB
Accession
0001192482-17-000329
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2017-12-27$9.54/sh−2,803$26,737→ 746,688 total - Sale
Common Stock
2017-12-26$9.59/sh−1,602$15,364→ 749,491 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2016.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.46 to $9.74, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.42 to $9.62, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001602484
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 4:21 PM ET
- Size
- 10.6 KB